Bile esculin agar

From WikiMD's WELLNESSPEDIA

Bile esculin agar (BEA) is a type of agar used in microbiology to isolate and identify members of the genus Enterococcus (Streptococcus group D). It is a selective and differential medium, which can distinguish between Enterococcus species and other gram-positive bacteria based on their ability to hydrolyze esculin in the presence of bile.

Composition[edit]

Bile esculin agar contains oxgall (bile), which inhibits the growth of most gram-positive bacteria but not Enterococcus. The medium also contains esculin, a glycoside, and ferric citrate. When esculin is hydrolyzed by the enzyme beta-glucosidase, it forms esculetin and glucose. Esculetin reacts with ferric citrate to form a dark brown or black complex.

Use[edit]

In a laboratory setting, a small inoculum of the test organism is streaked onto the surface of the bile esculin agar. The plate is then incubated at 35-37°C for 18-24 hours. If the organism can hydrolyze esculin in the presence of bile, the medium in the slant will turn dark brown or black. This is a positive result, indicating the presence of Enterococcus or group D Streptococcus. If the slant remains light, this is a negative result.

Limitations[edit]

While bile esculin agar is a useful tool in identifying Enterococcus and group D Streptococcus, it is not infallible. Some strains of Staphylococcus and Aerococcus can also hydrolyze esculin and may give a false positive result. Therefore, additional tests are often required to confirm the identification of the organism.

See also[edit]


Bile esculin agar gallery[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.